Tasleem Arif

1.8k total citations
31 papers, 1.3k citations indexed

About

Tasleem Arif is a scholar working on Molecular Biology, Cancer Research and Hematology. According to data from OpenAlex, Tasleem Arif has authored 31 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 10 papers in Cancer Research and 5 papers in Hematology. Recurrent topics in Tasleem Arif's work include Mitochondrial Function and Pathology (14 papers), Cancer, Hypoxia, and Metabolism (10 papers) and ATP Synthase and ATPases Research (5 papers). Tasleem Arif is often cited by papers focused on Mitochondrial Function and Pathology (14 papers), Cancer, Hypoxia, and Metabolism (10 papers) and ATP Synthase and ATPases Research (5 papers). Tasleem Arif collaborates with scholars based in Israel, United States and India. Tasleem Arif's co-authors include Varda Shoshan‐Barmatz, Anna Shteinfer‐Kuzmine, Yakov Krelin, Rajesh Dabur, T.K. Mandal, G S Lavekar, Naresh Kumar, Jitendra D. Bhosale, Ratnamala S. Bendre and Avijit Kumar Paul and has published in prestigious journals such as Blood, PLoS ONE and Cell stem cell.

In The Last Decade

Tasleem Arif

28 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tasleem Arif Israel	20	801	253	199	157	148	31	1.3k
Miran Jang South Korea	19	753 0.9×	272 1.1×	139 0.7×	122 0.8×	117 0.8×	76	1.5k
Hwan Myung Lee South Korea	21	811 1.0×	250 1.0×	123 0.6×	103 0.7×	52 0.4×	78	1.4k
Xia Ding China	24	1.2k 1.5×	349 1.4×	194 1.0×	146 0.9×	70 0.5×	53	1.8k
Sylvie Lamy Canada	22	717 0.9×	241 1.0×	174 0.9×	87 0.6×	55 0.4×	32	1.6k
Hyun Seok Kim South Korea	20	890 1.1×	245 1.0×	138 0.7×	165 1.1×	128 0.9×	45	1.4k
Huanjie Shao China	17	862 1.1×	285 1.1×	120 0.6×	45 0.3×	73 0.5×	37	1.4k
Yuh‐Charn Lin Taiwan	21	688 0.9×	164 0.6×	156 0.8×	159 1.0×	34 0.2×	31	1.4k
Xuyu Zu China	26	1.1k 1.4×	515 2.0×	70 0.4×	78 0.5×	90 0.6×	66	1.8k
Kwan‐Hyun Kim South Korea	14	604 0.8×	125 0.5×	160 0.8×	57 0.4×	307 2.1×	33	1.2k
Byung‐Doo Hwang South Korea	24	862 1.1×	314 1.2×	165 0.8×	41 0.3×	200 1.4×	73	1.7k

Countries citing papers authored by Tasleem Arif

Since Specialization

Citations

This map shows the geographic impact of Tasleem Arif's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tasleem Arif with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tasleem Arif more than expected).

Fields of papers citing papers by Tasleem Arif

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tasleem Arif. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tasleem Arif. The network helps show where Tasleem Arif may publish in the future.

Co-authorship network of co-authors of Tasleem Arif

This figure shows the co-authorship network connecting the top 25 collaborators of Tasleem Arif. A scholar is included among the top collaborators of Tasleem Arif based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tasleem Arif. Tasleem Arif is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Arif, Tasleem, Jiajing Qiu, Vijay Menon, et al.. (2025). Reversing lysosomal dysfunction restores youthful state in aged hematopoietic stem cells. Cell stem cell. 32(12). 1904–1922.e7.

Arif, Tasleem, Anna Shteinfer‐Kuzmine, & Varda Shoshan‐Barmatz. (2024). Decoding Cancer through Silencing the Mitochondrial Gatekeeper VDAC1. Biomolecules. 14(10). 1304–1304. 2 indexed citations

Shoshan‐Barmatz, Varda, Tasleem Arif, & Anna Shteinfer‐Kuzmine. (2023). Apoptotic proteins with non-apoptotic activity: expression and function in cancer. APOPTOSIS. 28(5-6). 730–753. 36 indexed citations

Liang, Raymond, Lin Miao, Vijay Menon, et al.. (2023). Elevated CDKN1A (P21) mediates β-thalassemia erythroid apoptosis, but its loss does not improve β-thalassemic erythropoiesis. Blood Advances. 7(22). 6873–6885. 4 indexed citations

Liang, Raymond, Vijay Menon, Jiajing Qiu, et al.. (2021). Mitochondrial localization and moderated activity are key to murine erythroid enucleation. Blood Advances. 5(10). 2490–2504. 18 indexed citations

Liang, Raymond, Tasleem Arif, Svetlana Kalmykova, et al.. (2020). Restraining Lysosomal Activity Preserves Hematopoietic Stem Cell Quiescence and Potency. Cell stem cell. 26(3). 359–376.e7. 164 indexed citations

Arif, Tasleem, et al.. (2019). Lysosomal Activation Is Required for Priming of Quiescent Hematopoietic Stem Cells. Blood. 134(Supplement_1). 722–722.

Arif, Tasleem, et al.. (2019). Metabolic Reprograming Via Silencing of Mitochondrial VDAC1 Expression Encourages Differentiation of Cancer Cells. Molecular Therapy — Nucleic Acids. 17. 24–37. 30 indexed citations

Arif, Tasleem, Avijit Kumar Paul, Yakov Krelin, Anna Shteinfer‐Kuzmine, & Varda Shoshan‐Barmatz. (2018). Mitochondrial VDAC1 Silencing Leads to Metabolic Rewiring and the Reprogramming of Tumour Cells into Advanced Differentiated States. Cancers. 10(12). 499–499. 48 indexed citations

10.

Shteinfer‐Kuzmine, Anna, et al.. (2018). Selective induction of cancer cell death by VDAC1‐based peptides and their potential use in cancer therapy. Molecular Oncology. 12(7). 1077–1103. 53 indexed citations

11.

Shteinfer‐Kuzmine, Anna, Tasleem Arif, Yakov Krelin, et al.. (2017). Mitochondrial VDAC1-based peptides: Attacking oncogenic properties in glioblastoma. Oncotarget. 8(19). 31329–31346. 23 indexed citations

12.

Paul, Avijit Kumar, Yakov Krelin, Tasleem Arif, Rina Jeger, & Varda Shoshan‐Barmatz. (2017). A New Role for the Mitochondrial Pro-apoptotic Protein SMAC/Diablo in Phospholipid Synthesis Associated with Tumorigenesis. Molecular Therapy. 26(3). 680–694. 29 indexed citations

13.

Arif, Tasleem, Yakov Krelin, & Varda Shoshan‐Barmatz. (2016). Reducing VDAC1 expression induces a non-apoptotic role for pro-apoptotic proteins in cancer cell differentiation. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1857(8). 1228–1242. 28 indexed citations

14.

Arif, Tasleem, Yakov Krelin, Itay Nakdimon, et al.. (2016). VDAC1 is a molecular target in glioblastoma, with its depletion leading to reprogrammed metabolism and reversed oncogenic properties. Neuro-Oncology. 19(7). 951–964. 65 indexed citations

15.

Nakdimon, Itay, et al.. (2016). Novel Biomarker Proteins in Chronic Lymphocytic Leukemia: Impact on Diagnosis, Prognosis and Treatment. PLoS ONE. 11(4). e0148500–e0148500. 15 indexed citations

16.

Sharma, Poonam, et al.. (2014). Pharmacology, Phytochemistry and Safety of Aphrodisiac Medicinal Plants: A Review. 2(3). 1–18. 9 indexed citations

17.

Keinan, Nurit, et al.. (2014). Ca2+-mediated regulation of VDAC1 expression levels is associated with cell death induction. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1843(10). 2270–2281. 88 indexed citations

18.

Arif, Tasleem, et al.. (2014). Silencing VDAC1 Expression by siRNA Inhibits Cancer Cell Proliferation and Tumor Growth In Vivo. Molecular Therapy — Nucleic Acids. 3. e159–e159. 128 indexed citations

19.

Arif, Tasleem, et al.. (2009). Screening of Some Selected Medicinal Plants Extracts for In-vitro Antimicrobial Activity. Middle East journal of scientific research. 4(4). 271–278. 34 indexed citations

20.

Arif, Tasleem, T.K. Mandal, Naresh Kumar, et al.. (2009). In vitro and in vivo antimicrobial activities of seeds of Caesalpinia bonduc (Lin.) Roxb.. Journal of Ethnopharmacology. 123(1). 177–180. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact